{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"US_8409564_B2","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"001-204-050-547-938","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11663,"type":"PATENT","title":"University of Montreal - Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":2579,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8327,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:uni* montreal
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 1939
Search Applicants and Owners separately:uni* montreal
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 1939
a) harvesting hematopoietic cells from a patient with an immunologic disorder;\n
b) harvesting hematopoietic cells from a donor;\n
c) mixing the cells of step a) with the cells of step b) ex vivo for a period of time sufficient to activate lymphocytes within the hematopoietic cells harvested from said donor such that an immune reaction occurs, wherein an activated portion and an unactivated portion is produced;\n
d) adding to the mixture of cells of step c) ex vivo a therapeutic amount of a rhodamine derivative according to formula (I):\n\nwherein R=methyl, ethyl, octyl or n-butyl;\n
e) irradiating the mixture of cells of step d) ex vivo with a suitable wavelength and intensity for the selective destruction and/or inactivation of the activated portion without substantially affecting the unactivated portion or causing systemic toxicity in said patient; and\n
f) infusing the mixture of cells of step e) into the patient."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said rhodamine derivative is of the formula (II):"],"number":2,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}